
浏览全部资源
扫码关注微信
南京中医药大学 附属医院,南京 210029
陈乐君,在读硕士,住院医师,从事肿瘤放射治疗研究,E-mail:clj213@126.com
于大海,博士,主任医师,从事肿瘤放射治疗研究,E-mail:yudahaipumc@hotmail.com
收稿日期:2021-09-26,
网络出版日期:2022-01-29,
纸质出版日期:2022-05-05
移动端阅览
陈乐君,黄腾,王逸君等.血府逐瘀汤对裸鼠食管癌移植瘤的放射增敏作用及机制[J].中国实验方剂学杂志,2022,28(09):23-28.
CHEN Le-jun,HUANG Teng,WANG Yi-jun,et al.Radiosensitization Effect and Mechanism of Xuefu Zhuyutang on Transplanted Esophageal Carcinoma in Nude Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(09):23-28.
陈乐君,黄腾,王逸君等.血府逐瘀汤对裸鼠食管癌移植瘤的放射增敏作用及机制[J].中国实验方剂学杂志,2022,28(09):23-28. DOI: 10.13422/j.cnki.syfjx.20220629.
CHEN Le-jun,HUANG Teng,WANG Yi-jun,et al.Radiosensitization Effect and Mechanism of Xuefu Zhuyutang on Transplanted Esophageal Carcinoma in Nude Mice[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(09):23-28. DOI: 10.13422/j.cnki.syfjx.20220629.
目的
2
探讨血府逐瘀汤对食管癌皮下移植瘤放射增敏的可能作用机制。
方法
2
建立人食管癌ECA-109裸鼠皮下移植瘤模型,将其随机分为模型组、单纯照射组、血府逐瘀汤组、联合组,每组6只。干预结束后剥除移植瘤并称量其质量,计算各组抑瘤率;然后用免疫组化法(IHC)检测缺氧诱导因子-1
α
(HIF-1
α
)、血管内皮生长因子A(VEGFA)蛋白表达,蛋白免疫印迹法(Western blot)检测移植瘤中人哺乳动物雷帕霉素靶蛋白(mTOR)、HIF-1
α
、VEGFA、血管内皮生长因子受体2(VEGFR2)蛋白表达;实时荧光定量聚合酶链式反应(Real-time PCR)检测移植瘤中mTOR、HIF-1
α
、VEGFA mRNA表达。
结果
2
与模型组比较,单纯照射组、血府逐瘀汤组瘤质量明显下降(
P
<
0.05),联合组瘤质量显著下降(
P
<
0.01);与单纯照射组比较,联合组瘤体质量明显下降(
P
<
0.05),该组抑瘤率达到57.37%;与模型组比较,单纯照射组、血府逐瘀汤组、联合组VEGFR2、p-mTOR、HIF-1
α、
VEGFA蛋白水平明显降低(
P
<
0.05,
P
<
0.01),单纯照射组、血府逐瘀汤组、联合组mTOR、HIF-1
α
,VEGFA mRNA水平明显降低(
P
<
0.05,
P
<
0.01);与单纯照射组比较,联合组VEGFR2、p-mTOR、HIF-1
α、
VEGFA蛋白表达明显下降(
P
<
0.05,
P
<
0.01),联合组mTOR、HIF-1
α
、VEGFA mRNA表达明显下降(
P
<
0.05,
P
<
0.01)。
结论
2
血府逐瘀汤可以抑制食管癌ECA109裸鼠移植瘤的生长,与放疗联用具有明显的放射增敏作用,其机制可能与抑制mTOR/HIF-1
α
/VEGFA乏氧信号通路的表达相关。
Objective
2
To explore the radiosensitization and underlying mechanism of Xuefu Zhuyutang on subcutaneous transplanted esophageal carcinoma.
Method
2
The subcutaneous xenograft model of human esophageal carcinoma ECA-109 in nude mice was induced and the model mice were divided into a model group, an irradiation group, a Xuefu Zhuyutang group, and a combination group, with six nude mice in each group. After the intervention, the transplanted tumors were removed and weighed, and the tumor inhibition rate of each group was calculated according to the formula. The protein expression of hypoxia-inducible factor-1
α
(HIF-1
α
) and vascular endothelial growth factor A (VEGFA) was detected by immunohistochemistry (IHC). The protein expression of mammalian target of rapamycin (mTOR), HIF-1
α
, VEGFA, and vascular endothelial growth factor receptor 2 (VEGFR2) in transplanted tumors was detected by Western blot. The mRNA expression of mTOR, HIF-1
α
, and VEGFA in transplanted tumors was detected by real-time quantitative polymerase chain reaction (Real-time PCR).
Result
2
Compared with the conditions in the model group, the tumor weight decreased in the irradiation group and the Xuefu Zhuyutang group (
P
<
0.05), as well as the combination group (
P
<
0.01). Compared with the irradiation group, the combination group showed decreased tumor weight (
P
<
0.05), with tumor inhibition rate of 57.37%. Compared with the model group, the irradiation group, the Xuefu Zhuyutang group, and the combination group showed decreased protein expression of VEGFR2, p-mTOR, HIF-1
α
, and VEGFA (
P
<
0.05,
P
<
0.01) and reduced mRNA expression of mTOR, HIF-1
α
, and VEGFA (
P
<
0.05,
P
<
0.01). Compared with the irradiation group, the combination group showed down-regulated protein expression of VEGFR2, p-mTOR, HIF-1
α
, and VEGFA (
P
<
0.05,
P
<
0.01) and reduced mRNA expression of mTOR, HIF-1
α
, and VEGFA (
P
<
0.05,
P
<
0.01).
Conclusion
2
Xuefu Zhuyutang can inhibit the growth of transplanted esophageal carcinoma ECA-109 in nude mice and shows an obvious radiosensitization effect in combination with radiotherapy. The mechanism may be related to the inhibition of the mTOR/HIF-1
α
/VEGFA signaling pathway to improve the hypoxic state of tumors.
BRAY F , FERLAY J , SOERJOMATARAM I , et al . Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2018 , 68 ( 6 ): 394 - 424 .
CHUN S G , SKINNER H D , MINSKY B D . Radiation therapy for locally advanced esophageal cancer [J]. Surg Oncol Clin N Am , 2017 , 26 ( 2 ): 257 - 276 .
李晔雄 , 殷蔚伯 , 余子豪 , 等 . 肿瘤放射治疗学 [M]. 北京 : 中国协和医科大学出版社 , 2018 : 826 .
BARKER H E , PAGET J T , KHAN A A , et al . The tumour microenvironment after radiotherapy:Mechanisms of resistance and recurrence [J]. Nat Rev Cancer , 2015 , 15 ( 7 ): 409 - 425 .
LIU J , ZHANG J , HUANG L , et al . Xuefu Zhuyu Tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment [J]. Onco Targets Ther , 2016 , 9 : 3603 - 3612 .
李延 , 田伟 , 马中龙 . 加味血府逐瘀汤抗肿瘤作用的实验研究 [J]. 世界中医药 , 2012 , 7 ( 1 ): 72 - 74 .
彭明尧 , 周雪宇 , 蒋利华 . VEGF、HIF-1 α 表达对食管鳞癌患者放疗疗效的影响 [J]. 实用癌症杂志 , 2020 , 35 ( 10 ): 1631 - 1634 .
刘俊波 , 黄常江 , 蔡凯 , 等 . 血府逐瘀汤防治急性放射性食管炎30例临床观察 [J]. 四川中医 , 2011 , 29 ( 9 ): 72 - 73 .
魏伟 , 吴希美 , 李元建 . 药理实验方法学 [M]. 北京 : 人民卫生出版社 , 2010 : 1698 .
余倩云 , 许建华 , 李朝衡 , 等 . “肠胃清”对结肠癌皮下移植瘤奥沙利铂治疗的增敏作用及对肿瘤组织坏死凋亡的影响研究 [J]. 江苏中医药 , 2018 , 50 ( 1 ): 75 - 78 .
ZHU H , YANG X , DING Y , et al . Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia [J]. Sci Rep , 2015 , 5 : 14503 .
QIN Q , CHENG H , LU J , et al . Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G 2 checkpoint and suppression of homologous recombination repair [J]. J Hematol Oncol , 2014 , 7 : 62 .
李周雷 , 张祥松 . 分子影像学与肿瘤乏氧(一):肿瘤乏氧机制 [J]. 影像诊断与介入放射学 , 2020 , 29 ( 6 ): 457 - 460 .
ZHANG H , SI J , YUE J , et al . The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma [J]. J Cancer Res Clin Oncol , 2021 , 147 ( 5 ): 1275 - 1286 .
郑玉玲 , 陈玉龙 . 中医药治疗食管癌研究述评 [J]. 中医肿瘤学杂志 , 2020 , 2 ( 3 ): 1 - 4 .
吴剑宏 , 陈幸谊 . 血府逐瘀汤方剂的现代药理研究进展 [J]. 中成药 , 2013 , 35 ( 5 ): 1054 - 1058 .
林建国 , 姚魁武 , 王擎擎 , 等 . 基于网络药理学和分子对接探讨血府逐瘀汤治疗心肌梗死的作用机制 [J]. 中国中药杂志 , 2021 , 46 ( 4 ): 885 - 893 .
SHI R , LIAO C , ZHANG Q . Hypoxia-driven effects in cancer:Characterization,mechanisms,and therapeutic implications [J]. Cells , 2021 , 10 ( 3 ): 678 .
SCHEUERMANN T H , YANG J , ZHANG L , et al . Hypoxia-inducible factors Per/ARNT/Sim domains: Structure and function [J]. Methods Enzymol , 2007 , 435 : 3 - 24 .
WIGERUP C , PAHLMAN S , BEXELL D . Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer [J]. Pharmacol Ther , 2016 , 164 : 152 - 169 .
MACEDO S C , MIRANDA G V , HENRIQUE R , et al . The critical role of hypoxic microenvironment and epigenetic deregulation in esophageal cancer radioresistance [J]. Genes (Basel) , 2019 , 10 ( 11 ): 927 .
JING S W , WANG J , XU Q . Expression of hypoxia inducible factor 1 alpha and its clinical significance in esophageal carcinoma:A Meta-analysis [J]. Tumour Biol , 2017 , 39 ( 7 ): 1010428317717983 .
ZHOU X , LIU H , ZHENG Y , et al . Overcoming radioresistance in tumor therapy by alleviating hypoxia and using the HIF-1 inhibitor [J]. ACS Appl Mater Interfaces , 2020 , 12 ( 4 ): 4231 - 4240 .
KELLY C J , HUSSIEN K , FOKAS E , et al . Regulation of O 2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia [J]. Radiother Oncol , 2014 , 111 ( 1 ): 72 - 80 .
SHAIK F , CUTHBERT G A , HOMER V S , et al . Structural basis for vascular endothelial growth factor receptor activation and implications for disease therapy [J]. Biomolecules , 2020 , 10 ( 12 ): 1673 .
JAYSON G C , KERBEL R , ELLIS L M , et al . Antiangiogenic therapy in oncology:Current status and future directions [J]. Lancet , 2016 , 388 ( 10043 ): 518 - 529 .
FU Z Z , SUN X D , LI P , et al . Relationship between serum VEGF level and radiosensitivity of patients with nonsmall cell lung cancer among asians:A Meta-analysis [J]. DNA Cell Biol , 2014 , 33 ( 7 ): 426 - 437 .
0
浏览量
29
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621